In non-endemic areas, the diagnosis of hepatitis A is no longer dependent on the detection of HAV RNA, but on positive anti-HAV-IgM, clinical manifestations, and biochemical indicators of liver injury, such as abnormal ALT and TBIL levels. The gene discussed is GPT; the disease is hepatitis A virus infection.